Works matching IS 11707690 AND DT 2023 AND VI 41 AND IP 4

Results: 9

Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review.
Published in:
2023
By:
- Li, Nannan;
- Beaudart, Charlotte;
- Cauley, Jane A.;
- Ing, Steven W.;
- Lane, Nancy E.;
- Reginster, Jean‑Yves;
- Silverman, Stuart;
- Singer, Andrea J.;
- Hiligsmann, Mickaël
Publication type:
Correction Notice
Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 353, doi. 10.1007/s40273-023-01247-w
By:
- Al Khayat, Mohamed N. M. T.;
- Armstrong, Nigel;
- Howick, Jeremy;
- O'Meara, Susan;
- Posadzki, Pawel;
- Ryder, Steve;
- Ahmadu, Charlotte;
- Konings, Stefan R. A.;
- Postma, Maarten J.;
- Duffy, Steven;
- Wolff, Robert F.;
- van Asselt, Antoinette D. I.
Publication type:
Article
The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 427, doi. 10.1007/s40273-023-01243-0
By:
- Norman, Richard;
- Mulhern, Brendan;
- Lancsar, Emily;
- Lorgelly, Paula;
- Ratcliffe, Julie;
- Street, Deborah;
- Viney, Rosalie
Publication type:
Article
Modelling the Cost-Effectiveness of Diagnostic Tests.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 339, doi. 10.1007/s40273-023-01241-2
By:
- Snowsill, Tristan
Publication type:
Article
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 363, doi. 10.1007/s40273-022-01239-2
By:
- Li, Nannan;
- Beaudart, Charlotte;
- Cauley, Jane A.;
- Ing, Steven W.;
- Lane, Nancy E.;
- Reginster, Jean-Yves;
- Silverman, Stuart;
- Singer, Andrea J.;
- Hiligsmann, Mickaël
Publication type:
Article
Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 395, doi. 10.1007/s40273-022-01238-3
By:
- Behr, Carina M.;
- Oude Wolcherink, Martijn J.;
- IJzerman, Maarten J.;
- Vliegenthart, Rozemarijn;
- Koffijberg, Hendrik
Publication type:
Article
Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 457, doi. 10.1007/s40273-022-01237-4
By:
- Thokala, Praveen;
- Hnynn Si, Pann Ei;
- Hernandez Alava, Monica;
- Sasso, Alessandro;
- Schaufler, Thilo;
- Soro, Marco;
- Fotheringham, James
Publication type:
Article
Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 413, doi. 10.1007/s40273-022-01236-5
By:
- Kim, John J.;
- Alsabbagh, Wasem;
- Wong, William W. L.
Publication type:
Article
Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study.
Published in:
PharmacoEconomics, 2023, v. 41, n. 4, p. 439, doi. 10.1007/s40273-022-01235-6
By:
- Zhang, Mengmeng;
- Bao, Yun;
- Yang, Yi;
- Kimber, Melissa;
- Levine, Mitchell;
- Xie, Feng
Publication type:
Article